Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Panjon Cough Syrup is an Ayurvedic proprietary medicine developed and marketed by Panjon Limited, an Indian consumer healthcare company. The product is formulated to provide symptomatic relief from various types of cough, including dry and productive cough, as well as associated respiratory symptoms such as sore throat and chest congestion. Unlike conventional pharmaceutical cough syrups that often contain synthetic agents like dextromethorphan or guaifenesin, Panjon Cough Syrup utilizes a blend of traditional Ayurvedic botanical extracts. Common ingredients in such formulations include Tulsi (Holy Basil), Vasaka (Adhatoda vasica), and Mulethi (Liquorice), which are traditionally recognized for their expectorant, antitussive, and anti-inflammatory properties. It is positioned as a natural, non-drowsy over-the-counter (OTC) alternative for respiratory health.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Panjon Cough Syrup.